Litcius/Paper detail

Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?

Mark J. Ratain, Ian F. Tannock, Allen S. Lichter

2021Journal of Clinical Oncology41 citationsDOI

Topics & Concepts

MedicineFood and drug administrationDrugDrug administrationAdministration (probate law)PharmacologyPolitical scienceLawChronic Myeloid Leukemia TreatmentsChemotherapy-induced cardiotoxicity and mitigationInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message? | Litcius